| EQUITY TRANSACTIONS |
NOTE
E – EQUITY TRANSACTIONS
Common
Stock
The
Company is authorized to issue 750,000,000 shares of common stock, $0.001 par value. The Company had 53,602,365 and 40,133,669 shares
of common stock issued and outstanding as of April 30, 2026, and April 30, 2025, respectively. The Company had 34,028,221 and 33,612,875
shares of common classified as to be issued at April 30, 2026, and April 30, 2025, respectively.
During
the year ended April 30, 2026, the Company
| |
● |
Issued
9,360,847 shares and converted 654,644 shares to be issued valued at $256,000 to accredited investors related to equity investments
which includes 2,153,216 warrants at fair value of $79,419 |
| |
● |
Issued
1,400,000 shares valued at $166,945 for consulting services |
| |
● |
Issued
136,809 shares of common stock valued at $19,985 upon the settlement of liability |
| |
● |
Issued
2,150,000 shares and 475,000 shares to be issued valued at $262,506 upon the conversion of convertible notes |
| |
● |
85,000
shares of common stock to be issued valued at $21,364 upon the issuance debt which includes 100,000 warrants at fair value of $11,474 |
| |
● |
50,000
shares of common stock to be issued valued at $4,000 to accredited investors relating to promissory notes |
| |
● |
Issued
21,040 shares of common stock valued at $5,260 upon the conversion of preferred series D shares. |
| |
● |
Issued
400,000 shares and 460,000 shares of common stock to be issued as penalty to noteholders valued at $157,246. |
During
the year ended April 30, 2025, the Company:
| |
● |
Issued
8,013,677 shares and 16,992 shares to be issued valued at $821,499 to accredited investors related to equity investments. |
| |
● |
Issued
953,956 shares valued at $232,856 for consulting services. |
| |
● |
664,847
shares of common stock to be issued as an incentive or penalty to noteholders valued at $255. |
| |
● |
Issued
850,000 shares of common stock valued at $85,000 upon the conversion of convertible notes |
| |
● |
Issued
36,000 shares valued at $6,000 upon the conversion of preferred series C shares |
| |
● |
Issued
120,000 shares valued at $30,000 upon the conversion of preferred series D shares |
Preferred
Stock
The
Company is authorized to issue 10,000,000 shares of preferred stock with $0.001 par value per share, of which 35,850 shares have been
designated as Series A convertible preferred stock with a $100 stated value per share; 1,000 shares have been designated as Series B
Preferred Stock with a $10,000 per share liquidation value; 4,200,000 shares have been designated as Series C Preferred Stock with a
$1 per share liquidation value, and 2,000,000 shares have been designated as Series D Preferred Stock with a $1 per share liquidation
value.
During
the years ended April 30, 2026, and 2025, the Company did not issue any preferred stock.
During
the year ended April 30, 2026, the Company
| |
● |
Converted
5,260 Series D preferred shares to 21,040 shares of common stock |
During
the year ended April 30, 2025, the Company
| |
● |
Converted
12,000 Series C preferred shares to 36,000 shares of common stock |
| |
● |
Converted
30,000 Series D preferred shares to 120,000 shares of common stock |
As
of April 30, 2026, and April 30, 2025, the Company had:
SCHEDULE
OF PREFERRED STOCK OUTSTANDING SHARES
| | |
April 30, | | |
April 30, | |
| Preferred stock outstanding shares | |
2026 | | |
2025 | |
| Series A | |
| 125 | | |
| 125 | |
| Series B | |
| - | | |
| - | |
| Series C | |
| 1,953,157 | | |
| 1,953,157 | |
| Series D | |
| 768,288 | | |
| 773,548 | |
| Preferred stock outstanding shares | |
| 768,288 | | |
| 773,548 | |
|